Neurocentria
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Pringle Ave, Walnut Creek, Californi...Phone Number
(925) 954-4868Website
www.neurocentria.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Neurocentria
Neurocentria Inc. is dedicated to developing innovative therapies for individuals with neuropsychiatric and neurodegenerative disorders. The company focuses on a unique mechanism of action that enhances synaptic function and promotes synaptogenesis through a proprietary compound that elevates intracellular magnesium levels. Their clinical programs include trials for ADHD, depression, and Alzheimer's disease, alongside a nutraceutical aimed at improving brain health for healthy individuals. With a patient-focused and science-backed approach, Neurocentria aims to provide life-changing treatment options.Explore more
Neurocentria Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurocentria your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Neurocentria
Check out if Neurocentria is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Neurocentria has recently received funding, and reach out quickly before it becomes old news!
Neurocentria, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Neurocentria had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Neurocentria recently announced quarterly report
Product Launch: Get notified when Neurocentria launches new products
Funding: Get notified immidiatlly once Neurocentria has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Neurocentria
Compare insights from companies similar to Neurocentria, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$6.6M
11-50
Private
-
-
DE
Darren EngersSenior Director of Medicinal Chemistry, Research Assistant Professor of Pharmacology
Company Profile Activity
Activity Insights
Neurocentria is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurocentria is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurocentria.
Neurocentria financials insights
Gather financial insights about Neurocentria, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Neurocentria Tech Stack
A closer look at the technologies used by Neurocentria
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurocentria
Sign Up For FreeTo access detailed company insights
Neurocentria Inc. is dedicated to developing innovative therapies for individuals with neuropsychiatric and neurodegenerative disorders. The company focuses on a unique mechanism of action that enhances synaptic function and promotes synaptogenesis through a proprietary compound that elevates intracellular magnesium levels. Their clinical programs... Read More
